The heterozygous mutations of neurofibromin cause neurofibromatosis type 1 (NF1) syndrome associated with benign tumors along the peripheral and optic nerves and malignant tumors such as neurofibrosarcomas, astrocytomas, and rhabdomyosarcomas [224,225,226,227,228]. The gene discussed is NF1; the disease is cancer.